Pathogenic mutations in MRPL3 were responsible for the clinical phenotype of combined oxidative phosphorylation deficiency-9 (COXPD9), in which severe hypertrophic cardiomyopathy is a central presentation [4]. This evidence concerns the gene MRPL3 and hypertrophic cardiomyopathy.